- RecruitingPHASE3
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
This study looks at a new medicine, pelacarsen, for people with heart and circulation problems and high levels of a specific fat called Lp(a). It aims to see if it's safe and effective when used alongside another medicine, inclisiran.
For: Atherosclerotic Cardiovascular Disease (ASCVD)United States · China · France - Active not recruitingPHASE3
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
This study looks at the long-term safety of a new medicine, pelacarsen, for people with high lipoprotein(a) and heart disease. It's for those who have already been in a previous study and will last about 5 years to see how they get on with the treatment.
For: Hyperlipoproteinemia (a)Germany